Cardlytics, Inc. (CDLX) Investigation

Cardlytics, Inc. is facing scrutiny from prominent shareholder rights firm Hagens Berman over its recent, bullish pronouncements on platform advancements and technological strides. The payments data platform provider had assured investors that these initiatives would be the catalyst for substantial growth, with management confidently asserting that the technology was “really paying off.”

However, these claims were sharply contradicted by the company’s Q2 2024 financial results, released on August 7, which fell dramatically short of revenue projections issued just three months prior. Cardlytics attributed the shortfall to “fast-paced changes to our technology platform,” leading to unpredictable advertiser spending and a projected 7% to 13% decline in billings for Q3 2024.

Adding to investor concerns, in response to analyst inquiry, management disclosed that the platform’s delivery issues had been evident for “a quarter or two.”

The revelation sent Cardlytics shares into a tailspin, plummeting 57% on August 8, 2024.

FREQUENTLY ASKED QUESTIONS ABOUT THE CASE

What is the CDLX investigation about?

We are investigating whether Cardlytics may have misled investors about the prospects for its growth initiatives.

WHAT SHOULD I DO?

I worked at CDLX. What should I do?

If you were an employee of CDLX, you may have valuable information that could be relevant to the investigation. Hagens Berman is one of the nation’s top whistleblower law firms, and has successfully represented many individuals who come forward with information regarding corporate malfeasance. Under the new SEC Whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, contact Reed Kathrein at 844-916-0895 or [email protected].

There are multiple law firms participating, do I need to contact all of them?

No, you do not need to contact all participating law firms. Generally, class-action investigations and lawsuits are consolidated into a single case to streamline the legal process, and attorneys from only a few law firms are selected to serve in a leadership role on the consolidated case. Hagens Berman has a proven track record of being appointed to leadership roles in complex, multidistrict litigation regarding investor fraud and other consumer rights issues, and your claim will be handled by attorneys who have helped secure approximately $325 billion in class-action settlements on behalf of individuals who have suffered due to corporate malfeasance and the wrongdoing of other powerful institutions.

AM I ELIGIBLE?

What is the threshold amount to be eligible? What are “substantial” losses?

The threshold amount and the definition of "substantial" losses may vary depending on a number of factors specific to the case, including the size of the company, market cap, shares outstanding and who holds them and the damages alleged by the fraud. In general, to be eligible to participate in a class-action lawsuit, you must be able to demonstrate that you suffered financial losses as a result of the alleged wrongdoing and that your losses meet the criteria set by the court or law firm. Fill out the form and submit your losses.

CAN I PARTICIPATE?

Am I affected? What do I need to do to participate?

If you were an investor in CDLX, you may be affected and eligible to participate in the case. To determine your eligibility and potential involvement, fill out the form and submit your losses.

Can any CDLX investor participate?

In most class-action investigations and cases, any investor who meets the eligibility criteria, including purchasing the shares during the relevant period, can participate, regardless of the size of their investment. Fill out the form to find out your rights.

I bought on a non-U.S. Exchange. Can I participate?

No. This investigation only covers shares bought on a U.S. exchange, i.e. NASDAQ or NYSE. Fill out the form to find out your rights.

Am I included if I still hold my shares, or do I need to sell to participate?

Participation is based on purchasing shares during the relevant period, rather than your current holdings. Accordingly, you do not need to sell to participate. Fill out the form to find out your rights.